Burning Rock Biotech (BNR) Other Operating Expenses (2020 - 2025)
Historic Other Operating Expenses for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$5.9 million.
- Burning Rock Biotech's Other Operating Expenses rose 1487.17% to -$5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$28.1 million, marking a year-over-year decrease of 351.64%. This contributed to the annual value of -$31.0 million for FY2024, which is 8042.86% up from last year.
- Latest data reveals that Burning Rock Biotech reported Other Operating Expenses of -$5.9 million as of Q3 2025, which was up 1487.17% from -$5.4 million recorded in Q2 2025.
- Over the past 5 years, Burning Rock Biotech's Other Operating Expenses peaked at -$5.4 million during Q2 2025, and registered a low of -$16.2 million during Q4 2021.
- Over the past 5 years, Burning Rock Biotech's median Other Operating Expenses value was -$9.4 million (recorded in 2023), while the average stood at -$9.7 million.
- In the last 5 years, Burning Rock Biotech's Other Operating Expenses plummeted by 9603.87% in 2021 and then surged by 4321.81% in 2023.
- Burning Rock Biotech's Other Operating Expenses (Quarter) stood at -$16.2 million in 2021, then increased by 23.76% to -$12.3 million in 2022, then skyrocketed by 43.22% to -$7.0 million in 2023, then tumbled by 59.93% to -$11.2 million in 2024, then surged by 47.63% to -$5.9 million in 2025.
- Its Other Operating Expenses was -$5.9 million in Q3 2025, compared to -$5.4 million in Q2 2025 and -$5.6 million in Q1 2025.